A citation-based method for searching scientific literature

Feras M Ghazawi, Farhan Mahmood, Leon Kircik, Yves Poulin, Marc Bourcier, Ronald Vender, Marni C Wiseman, Charles Lynde, Ivan V Litvinov. Front Med (Lausanne) 2021
Times Cited: 4







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis.
S K Mahil, M C Ezejimofor, L S Exton, L Manounah, A D Burden, L C Coates, M de Brito, A McGuire, R Murphy, C M Owen,[...]. Br J Dermatol 2020
22
50

Psoriasis and comorbid diseases: Epidemiology.
Junko Takeshita, Sungat Grewal, Sinéad M Langan, Nehal N Mehta, Alexis Ogdie, Abby S Van Voorhees, Joel M Gelfand. J Am Acad Dermatol 2017
383
50

Psoriasis.
Wolf-Henning Boehncke, Michael P Schön. Lancet 2015
50

Psoriasis Pathogenesis and Treatment.
Adriana Rendon, Knut Schäkel. Int J Mol Sci 2019
375
50

A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis.
K A Papp, K Reich, C Paul, A Blauvelt, W Baran, C Bolduc, D Toth, R G Langley, J Cather, A B Gottlieb,[...]. Br J Dermatol 2016
279
50

Kinase inhibition in autoimmunity and inflammation.
Ali A Zarrin, Katherine Bao, Patrick Lupardus, Domagoj Vucic. Nat Rev Drug Discov 2021
78
25

Suppression of proteoglycan-induced arthritis by anti-CD20 B Cell depletion therapy is mediated by reduction in autoantibodies and CD4+ T cell reactivity.
Keith Hamel, Paul Doodes, Yanxia Cao, Yumei Wang, Jeffrey Martinson, Robert Dunn, Marilyn R Kehry, Balint Farkas, Alison Finnegan. J Immunol 2008
73
25

How citrullination invaded rheumatoid arthritis research.
Walther J van Venrooij, Ger J M Pruijn. Arthritis Res Ther 2014
23
25

Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis.
Laura Chadwick, Sizheng Zhao, Eduardo Mysler, Robert J Moots. Curr Rheumatol Rep 2018
17
25

Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348).
T Zhou, S Georgeon, R Moser, D J Moore, A Caflisch, O Hantschel. Leukemia 2014
78
25



The Role of Posttranslational Protein Modifications in Rheumatological Diseases: Focus on Rheumatoid Arthritis.
Andrea Mastrangelo, Tania Colasanti, Cristiana Barbati, Arbi Pecani, Danilo Sabatinelli, Monica Pendolino, Simona Truglia, Laura Massaro, Riccardo Mancini, Francesca Miranda,[...]. J Immunol Res 2015
34
25

Basic Mechanisms of JAK Inhibition.
Chung Ma Lin, Faye Ah Cooles, John D Isaacs. Mediterr J Rheumatol 2020
7
25

Adalimumab for treating rheumatoid arthritis.
Federico Navarro-Sarabia, Rafael Ariza-Ariza, Blanca Hernández-Cruz, Isidro Villanueva. J Rheumatol 2006
25
25

Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations.
Peleg Rider, Yaron Carmi, Idan Cohen. Int J Cell Biol 2016
98
25

Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis.
Jillian Frieder, Dario Kivelevitch, Alan Menter. Ther Adv Chronic Dis 2018
79
25

Ruxolitinib, a JAK1/2 Inhibitor, Ameliorates Cytokine Storm in Experimental Models of Hyperinflammation Syndrome.
Eduardo Huarte, Michael T Peel, Katherine Verbist, Brittany L Fay, Rachel Bassett, Sabrin Albeituni, Kim E Nichols, Paul A Smith. Front Pharmacol 2021
6
25

Current prospects of type II interferon γ signaling and autoimmunity.
Daniel S Green, Howard A Young, Julio C Valencia. J Biol Chem 2017
84
25

Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.
Dror Luger, Phyllis B Silver, Jun Tang, Daniel Cua, Zoe Chen, Yoichiro Iwakura, Edward P Bowman, Nicole M Sgambellone, Chi-Chao Chan, Rachel R Caspi. J Exp Med 2008
533
25



Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study.
Sudha Visvanathan, Stefan Daniluk, Rafał Ptaszyński, Ulf Müller-Ladner, Meera Ramanujam, Bernd Rosenstock, Anastasia G Eleftheraki, Richard Vinisko, Alena Petříková, Herbert Kellner,[...]. Ann Rheum Dis 2019
25
25

Adalimumab for treating rheumatoid arthritis.
F Navarro-Sarabia, R Ariza-Ariza, B Hernandez-Cruz, I Villanueva. Cochrane Database Syst Rev 2005
69
25

J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells.
P R Taylor, G K Koski, C C Paustian, E Bailey, P A Cohen, F B-G Moore, D H Zimmerman, K S Rosenthal. Vaccine 2010
18
25

Lessons from next generation influenza vaccines for inflammatory disease therapies.
Daniel H Zimmerman, Roy E Carambula, Jason Ciemielewski, Ken S Rosenthal. Int Immunopharmacol 2019
2
50

Anakinra Therapy for Non-cancer Inflammatory Diseases.
Giulio Cavalli, Charles A Dinarello. Front Pharmacol 2018
130
25

JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis.
Rita A Moura, João Eurico Fonseca. Front Med (Lausanne) 2021
13
25

Th17 and CD24hiCD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis.
Sarah Salomon, Caroline Guignant, Pierre Morel, Gauthier Flahaut, Clément Brault, Clément Gourguechon, Patrice Fardellone, Jean-Pierre Marolleau, Brigitte Gubler, Vincent Goëb. Arthritis Res Ther 2017
29
25

Causal risk and protective factors in rheumatoid arthritis: A genetic update.
M Arleevskaya, E Takha, S Petrov, G Kazarian, A Novikov, R Larionova, A Valeeva, E Shuralev, M Mukminov, C Bost,[...]. J Transl Autoimmun 2021
4
25

Association between serum bone biomarker levels and therapeutic response to abatacept in patients with rheumatoid arthritis (RA): a multicenter, prospective, and observational RA ultrasound cohort study in Japan.
Shin-Ya Kawashiri, Yushiro Endo, Ayako Nishino, Momoko Okamoto, Sosuke Tsuji, Ayuko Takatani, Toshimasa Shimizu, Remi Sumiyoshi, Tomohiro Koga, Naoki Iwamoto,[...]. BMC Musculoskelet Disord 2021
4
25

The anti-CD6 antibody itolizumab provides clinical benefit without lymphopenia in rheumatoid arthritis patients: results from a 6-month, open-label Phase I clinical trial.
P C Rodríguez, D M Prada, E Moreno, L E Aira, C Molinero, A M López, J A Gómez, I M Hernández, J P Martínez, Y Reyes,[...]. Clin Exp Immunol 2018
14
25


Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
M J Elliott, R N Maini, M Feldmann, A Long-Fox, P Charles, P Katsikis, F M Brennan, J Walker, H Bijl, J Ghrayeb. Arthritis Rheum 1993
681
25

Fedratinib: First Approval.
Hannah A Blair. Drugs 2019
41
25

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.
Daniella M Schwartz, Yuka Kanno, Alejandro Villarino, Michael Ward, Massimo Gadina, John J O'Shea. Nat Rev Drug Discov 2017
382
25

The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells.
Keisuke Maeshima, Kunihiro Yamaoka, Satoshi Kubo, Kazuhisa Nakano, Shigeru Iwata, Kazuyoshi Saito, Masanobu Ohishi, Hisaaki Miyahara, Shinya Tanaka, Koji Ishii,[...]. Arthritis Rheum 2012
149
25

JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib.
Paqui G Traves, Bernard Murray, Federico Campigotto, René Galien, Amy Meng, Julie A Di Paolo. Ann Rheum Dis 2021
29
25

CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model.
Daniel H Zimmerman, Patricia Taylor, Alison Bendele, Roy Carambula, Yvonne Duzant, Valeria Lowe, Sean P O'Neill, Eyal Talor, Kenneth S Rosenthal. Int Immunopharmacol 2010
27
25

Humoral Epitope Spreading in Autoimmune Bullous Diseases.
Dario Didona, Giovanni Di Zenzo. Front Immunol 2018
43
25

Janus kinase inhibitors in autoimmune diseases.
John J O'Shea, Apostolos Kontzias, Kunihiro Yamaoka, Yoshiya Tanaka, Arian Laurence. Ann Rheum Dis 2013
245
25

Infectious Triggers in Periodontitis and the Gut in Rheumatoid Arthritis (RA): A Complex Story About Association and Causality.
Burkhard Möller, Florian Kollert, Anton Sculean, Peter M Villiger. Front Immunol 2020
17
25

Crosstalk between B cells and neutrophils in rheumatoid arthritis.
Utsa Karmakar, Sonja Vermeren. Immunology 2021
8
25

Rheumatoid arthritis.
Josef S Smolen, Daniel Aletaha, Anne Barton, Gerd R Burmester, Paul Emery, Gary S Firestein, Arthur Kavanaugh, Iain B McInnes, Daniel H Solomon, Vibeke Strand,[...]. Nat Rev Dis Primers 2018
721
25

How interferon-gamma keeps autoimmune diseases in check.
Hilde Kelchtermans, Alfons Billiau, Patrick Matthys. Trends Immunol 2008
129
25

Immunological evaluation of rheumatoid arthritis patients treated with itolizumab.
Lazaro E Aira, Patricia Hernández, Dinorah Prada, Araceli Chico, Jorge A Gómez, Zuyén González, Karla Fuentes, Carmen Viada, Zaima Mazorra. MAbs 2016
15
25

Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation.
Marek Wieczorek, Esam T Abualrous, Jana Sticht, Miguel Álvaro-Benito, Sebastian Stolzenberg, Frank Noé, Christian Freund. Front Immunol 2017
334
25

Signaling and Function of Interleukin-2 in T Lymphocytes.
Sarah H Ross, Doreen A Cantrell. Annu Rev Immunol 2018
250
25

Post-translational modifications in rheumatoid arthritis and atherosclerosis: Focus on citrullination and carbamylation.
Francesca Romana Spinelli, Arbi Pecani, Fabrizio Conti, Riccardo Mancini, Cristiano Alessandri, Guido Valesini. J Int Med Res 2016
17
25

T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab.
Usha Bughani, Arindam Saha, Anshu Kuriakose, Reshmi Nair, Ravindra B Sadashivarao, Rasika Venkataraman, Swati Patel, Anuja Tushar Deshchougule, Satish Kumar S, Enrique Montero,[...]. PLoS One 2017
26
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.